Krystal Biotech buy Chardan Capital
Start price
22.08.25
/
50%
€127.05
Target price
22.08.26
€186.08
Performance (%)
59.62%
Price
19:13
€202.80
Summary
This prediction is currently active. With a performance of 59.62% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 22.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 8.522% | 8.522% |
| iShares Core DAX® | 1.917% | 1.088% |
| iShares Nasdaq 100 | 0.911% | 1.674% |
| iShares Nikkei 225® | 0.833% | -1.712% |
| iShares S&P 500 | 0.242% | 1.258% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target lowered by analysts at Chardan Capital from $219.00 to $216.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat